<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html xmlns:o="urn:schemas-microsoft-com:office:office" __expr-val-dir="ltr" dir="ltr"><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
<meta name="GENERATOR" content="Microsoft SharePoint"/><meta name="progid" content="SharePoint.WebPartPage.Document"/><meta http-equiv="Expires" content="0"/><title>
	Proposed Revision | APA DSM-5
</title><link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorCustomStyles.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/HtmlEditorTableFormats.css"/>
<link rel="stylesheet" type="text/css" href="../../_layouts/1033/styles/core.css"/>
<link rel="stylesheet" type="text/css" href="../../Style Library/DSM_Css/DSM.css"/>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/init.js"></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/core.js" defer></script>
<script type="text/javascript" language="javascript" src="../../_layouts/1033/non_ie.js"></script>
<link type="text/xml" rel="alternate" href="http://www.dsm5.org/proposedrevision/_vti_bin/spsdisco.aspx"/>
	<style type="text/css">
		#DSM_MainContent {
			background-color: transparent;
			padding: 0px;
		}			
	</style>
<!--[if gte mso 9]><xml>
<o:CustomDocumentProperties>
<o:PublishingContactPicture msdt:dt="string" dt="string">, </o:PublishingContactPicture></o:CustomDocumentProperties></xml><![endif]-->
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery-1.3.2.min.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery/jquery.easing.1.3.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.js"></script>
<script type="text/javascript" src="../../_layouts/Emagination.jQuery.SPServices/jquery.SPServices-0.5.7.min.js"></script><script language="javascript" src="../../Style Library/DSM_js/RevisionTabs.js" type="text/javascript"></script><script language="javascript" src="../../Style Library/DSM_js/search.js" type="text/javascript"></script></head><body style="background:url(../../Style%20Library/DSM_Images/background.gif) repeat-x;margin:0px;" scroll="yes" onload="javascript:if (typeof(_spBodyOnLoadWrapper) != 'undefined') _spBodyOnLoadWrapper();"><form name="aspnetForm" method="post" action="../../ProposedRevision/Pages/proposedrevision_rid_411.html" id="aspnetForm">
<input type="hidden" name="MSO_PageHashCode" id="MSO_PageHashCode" value="5295-48993826"/>
<input type="hidden" name="__SPSCEditMenu" id="__SPSCEditMenu" value="true"/>
<input type="hidden" name="MSOWebPartPage_PostbackSource" id="MSOWebPartPage_PostbackSource" value=""/>
<input type="hidden" name="MSOTlPn_SelectedWpId" id="MSOTlPn_SelectedWpId" value=""/>
<input type="hidden" name="MSOTlPn_View" id="MSOTlPn_View" value="0"/>
<input type="hidden" name="MSOTlPn_ShowSettings" id="MSOTlPn_ShowSettings" value="False"/>
<input type="hidden" name="MSOGallery_SelectedLibrary" id="MSOGallery_SelectedLibrary" value=""/>
<input type="hidden" name="MSOGallery_FilterString" id="MSOGallery_FilterString" value=""/>
<input type="hidden" name="MSOTlPn_Button" id="MSOTlPn_Button" value="none"/>
<input type="hidden" name="__REQUESTDIGEST" id="__REQUESTDIGEST" value="0x1C95E0135501ACB04BAA7C2E3AEB5120DDD15CE4ADA471C0CF0A325C1D1609C3EECE077A99E9C3B83DED70747AF17800CA63E14545AE094564FAF2CCDCC7CB55,20 Oct 2012 11:38:25 -0000"/>
<input type="hidden" name="MSOAuthoringConsole_FormContext" id="MSOAuthoringConsole_FormContext" value=""/>
<input type="hidden" name="MSOAC_EditDuringWorkflow" id="MSOAC_EditDuringWorkflow" value=""/>
<input type="hidden" name="MSOSPWebPartManager_DisplayModeName" id="MSOSPWebPartManager_DisplayModeName" value="Browse"/>
<input type="hidden" name="MSOWebPartPage_Shared" id="MSOWebPartPage_Shared" value=""/>
<input type="hidden" name="MSOLayout_LayoutChanges" id="MSOLayout_LayoutChanges" value=""/>
<input type="hidden" name="MSOLayout_InDesignMode" id="MSOLayout_InDesignMode" value=""/>
<input type="hidden" name="MSOSPWebPartManager_OldDisplayModeName" id="MSOSPWebPartManager_OldDisplayModeName" value="Browse"/>
<input type="hidden" name="MSOSPWebPartManager_StartWebPartEditingName" id="MSOSPWebPartManager_StartWebPartEditingName" value="false"/>
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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"/>
<script> var MSOWebPartPageFormName = 'aspnetForm';</script>
<script type="text/javascript">
//<![CDATA[
                function DoCallBack(filterText)
                {
                    WebForm_DoCallback('ctl00$m$g_df258af6_3061_4b80_a680_48204ee9cef4',filterText,UpdateFilterCallback,0,CallBackError,true);
                }
                function CallBackError(result, clientsideString)
                {                
                }
var globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71;
var globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71;
function ExpGroupCallServerg_3cf5e074_39b0_425f_92e8_f3c760a6ce71(arg, context)
{
    globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71 = "GroupString=" + arg + "&ConnectionFilterString=";
    globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71 = context;
    setTimeout("WebForm_DoCallback('ctl00$m$g_3cf5e074_39b0_425f_92e8_f3c760a6ce71',globalArg_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71,ExpGroupReceiveData,globalContext_g_3cf5e074_39b0_425f_92e8_f3c760a6ce71,ExpGroupOnError,true)", 0);
}
function ExpGroupOnError(message, context) {
alert('An error has occurred with the data fetch.  Please refresh the page and retry.');
}
if (typeof(_spBodyOnLoadFunctionNames) != "undefined") {
if (_spBodyOnLoadFunctionNames != null) {
_spBodyOnLoadFunctionNames.push("ExpGroupOnPageLoad");
}
}//]]>
</script>
<script src="../../WebResource.axd_d_T_sWwmChWv5_0o-vuzl71g2_t_633965588901821931.js" type="text/javascript"></script>
<!-- begin MAIN LAYOUT -->
		<div id="DSM_MainContainer">
			<div id="DSM_Header">	
	<!---- begin ACCESSIBILITY FEATURE ---->
					<div id="TurnOnAccessibility" style="display:none">
			   		<a href="#" class="ms-skip" onclick="SetIsAccessibilityFeatureEnabled(true);UpdateAccessibilityUI();return false;">
					Turn on more accessible mode</a></div>
					<a href="javascript:;" onclick="javascript:this.href='#mainContent';" class="ms-skip" accesskey="J">
					Skip to main content</a>
			  		<div id="TurnOffAccessibility" style="display:none">
					<a href="#" class="ms-acclink" onclick="SetIsAccessibilityFeatureEnabled(false);UpdateAccessibilityUI();return false;">
					Turn off more accessible mode</a></div>
	<!---- end ACCESSIBILITY FEATURE ---->
	<!-- begin UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
	<div id="SP_adminBar">
		<tr><td colspan="4" id="mpdmconsole" class="ms-consolemptablerow">
<!-- Console -->
<span id="ctl00_SPNavigation_ctl01_publishingContext1"></span>
<!-- Console -->
</td></tr>
	</div>
<!-- end UPPER BAR for SITE ACTIONS and EDITING ELEMENTS -->
				<h1><a href="/">American Psychiatric Association DSM-5 Development</a></h1>	
				<div id="DSM_UtilityLinks"><a href="http://www.psychiatry.org/">www.psychiatry.org</a></div>
				<!--<div id="DSM_UtilityLinks3"><a href="/pages/registration.aspx">Volunteer for Field Trials</a></div>-->
				<div id="DSM_UtilityLinks2"><a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use</a></div>
				<div id="DSM_SearchForm">
					<table>
						<tr>
							<td><input type="text" id="searchTerm" onkeydown="searchSubmitEnter()"/></td>
							<td><img src="../../Style Library/DSM_Images/search.gif" alt="Search" id="searchBtn" onclick="searchSubmitClick()"/></td>
						</tr>
					</table>					
				</div>			
			</div>	
			<div id="DSM_TopNavBar">
<!---- begin TOP NAVIGATION ---->		
			<table id="zz1_TopNavigationMenu" class="ms-topNavContainer" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td onmouseover="Menu_HoverRoot(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun0"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
			<tr>
				<td><a class="DSM_staticNavItem" href="/" accesskey="1">Home</a></td>
			</tr>
		</table></td><td width="0"></td><td><table border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="About DSM-5" id="zz1_TopNavigationMenun1"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../about/Pages/Default.html">About DSM-5</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Meet Us" id="zz1_TopNavigationMenun2"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../MeetUs/Pages/Default.html">Meet Us</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Research Background" id="zz1_TopNavigationMenun3"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../Research/Pages/Default.html">Research Background</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="General Resources" id="zz1_TopNavigationMenun4"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../ProgressReports/Pages/Default.html">General Resources</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-5 Proposed Revisions" id="zz1_TopNavigationMenun5"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></td>
					</tr>
				</table></td><td width="0"></td><td width="0"></td><td onmouseover="Menu_HoverStatic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Newsroom" id="zz1_TopNavigationMenun6"><table class="DSM_staticNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
					<tr>
						<td><a class="DSM_staticNavItem" href="../../Newsroom/Pages/Default.html">Newsroom</a></td>
					</tr>
				</table></td><td width="0"></td>
			</tr>
		</table><div id="zz1_TopNavigationMenun1Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="DSM-V Overview" id="zz1_TopNavigationMenun7">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/DSMVOverview.html">DSM-5 Overview: The Future Manual</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Timeline" id="zz1_TopNavigationMenun8">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/Timeline.html">Timeline</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Board of Trustee Principles" id="zz1_TopNavigationMenun9">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Frequently Asked Questions" id="zz1_TopNavigationMenun10">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun1ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun1ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun2Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Task Force Members" id="zz1_TopNavigationMenun11">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/TaskForceMembers.html">Task Force Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Study Group Members" id="zz1_TopNavigationMenun12">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/StudyGroupMembers.html">Study Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Work Group Members" id="zz1_TopNavigationMenun13">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../MeetUs/Pages/WorkGroupMembers.html">Work Group Members</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun14">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/BoardofTrusteePrinciples.html">Board of Trustee Principles</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun2ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun2ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun3Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun15">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/ConferenceSummariesandMonographs.html">DSM-5 Research Planning Conference Summaries and Monographs</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun16">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/Presentations.html">Presentations on DSM-5 and Related Topics</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun17">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/Publications.html">Publications from DSM-5 Development</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun18">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Research/Pages/DSM-5FieldTrials.html">DSM-5 Field Trials</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun3ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun3ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun5Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurodevelopmental Disorders" id="zz1_TopNavigationMenun19">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/NeurodevelopmentalDisorders.html">Neurodevelopmental Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Schizophrenia Spectrum and Other Psychotic Disorders" id="zz1_TopNavigationMenun20">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.html">Schizophrenia Spectrum and Other Psychotic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Bipolar and Related Disorders" id="zz1_TopNavigationMenun21">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/BipolarandRelatedDisorders.html">Bipolar and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Depressive Disorders" id="zz1_TopNavigationMenun22">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/DepressiveDisorders.html">Depressive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Anxiety Disorders" id="zz1_TopNavigationMenun23">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/AnxietyDisorders.html">Anxiety Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Obsessive-Compulsive and Related Disorders" id="zz1_TopNavigationMenun24">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Obsessive-CompulsiveandRelatedDisorders.html">Obsessive-Compulsive and Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Trauma and Stressor Related Disorders" id="zz1_TopNavigationMenun25">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/TraumaandStressorRelatedDisorders.html">Trauma- and Stressor-Related Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Dissociative Disorders" id="zz1_TopNavigationMenun26">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/DissociativeDisorders.html">Dissociative Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Somatic Symptom Disorders" id="zz1_TopNavigationMenun27">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SomaticSymptomDisorders.html">Somatic Symptom Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Feeding and Eating Disorders" id="zz1_TopNavigationMenun28">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/FeedingandEatingDisorders.html">Feeding and Eating Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Elimination Disorders" id="zz1_TopNavigationMenun29">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/EliminationDisorders.html">Elimination Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sleep-Wake Disorders" id="zz1_TopNavigationMenun30">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Sleep-WakeDisorders.html">Sleep-Wake Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Sexual Dysfunctions" id="zz1_TopNavigationMenun31">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SexualDysfunctions.html">Sexual Dysfunctions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Gender Dysphoria" id="zz1_TopNavigationMenun32">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/GenderDysphoria.html">Gender Dysphoria</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Disruptive, Impulse Control, and Conduct Disorders" id="zz1_TopNavigationMenun33">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Disruptive_ImpulseControl_andConductDisorders.html">Disruptive, Impulse Control, and Conduct Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Substance Use and Addictive Disorders" id="zz1_TopNavigationMenun34">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/SubstanceUseandAddictiveDisorders.html">Substance Use and Addictive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Neurocognitive Disorders" id="zz1_TopNavigationMenun35">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/NeurocognitiveDisorders.html">Neurocognitive Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Personality Disorders" id="zz1_TopNavigationMenun36">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/PersonalityDisorders.html">Personality Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Paraphilic Disorders" id="zz1_TopNavigationMenun37">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/ParaphilicDisorders.html">Paraphilic Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Other Disorders" id="zz1_TopNavigationMenun38">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/OtherDisorders.html">Other Disorders</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed DSM-5 Organizational Structure and Disorder Names" id="zz1_TopNavigationMenun39">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure and Disorder Names</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="Proposed Mental Disorder Definitions" id="zz1_TopNavigationMenun40">
					<td><table class="DSM_dynamicNavSelected DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavSelected DSM_dynamicNavItem" href="../../proposedrevision/Pages/proposedrevision_rid_465.html">Proposed Mental Disorder Definitions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun41">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../proposedrevision/Pages/Cult.html">DSM-5 Cultural Formulation Interview</a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun5ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun5ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div><div id="zz1_TopNavigationMenun6Items" class="DSM_dynamicNav" style="display:none;">
			<table border="0" cellpadding="0" cellspacing="0">
				<tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun42">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/PressReleases.html">Press Releases</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun43">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/MediaContact.html">Media Contact</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" title="FAQ" id="zz1_TopNavigationMenun44">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../about/Pages/faq.html">Frequently Asked Questions</a></td>
						</tr>
					</table></td>
				</tr><tr onmouseover="Menu_HoverDynamic(this)" onmouseout="Menu_Unhover(this)" onkeyup="Menu_Key(event)" id="zz1_TopNavigationMenun45">
					<td><table class="DSM_dynamicNavItem" cellpadding="0" cellspacing="0" border="0" width="100%">
						<tr>
							<td width="100%"><a class="DSM_dynamicNavItem" href="../../Newsroom/Pages/Commentaries.html">Commentaries, Responses, and Other DSM-5 News </a></td>
						</tr>
					</table></td>
				</tr>
			</table><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun6ItemsUp" onmouseover="PopOut_Up(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_phB4qr5l5XdYTogepU-nLVPsS06Zdiww2yA7um6d8Uc1_t_633965588901821931.jpg" alt="Scroll up"/>
			</div><div class="DSM_dynamicNavItem" id="zz1_TopNavigationMenun6ItemsDn" onmouseover="PopOut_Down(this)" onmouseout="PopOut_Stop(this)" align="center" style="display:none;">
				<img src="../../WebResource.axd_d_IWy_nidJ9_kgiwIM-q3dD_Ob45B5V7Xiyd7xd9M5gWA1_t_633965588901821931.jpg" alt="Scroll down"/>
			</div>
		</div></td>
	</tr>
</table>
<!---- end TOP NAVIGATION ---->
		</div>
			<div id="DSM_MainContent">
<!---- begin MAIN CONTENT AREA ---->
		<a name="mainContent"></a>
	<div id="DSM_LeftCol">												
		<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ1" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="df258af6-3061-4b80-a680-48204ee9cef4" haspers="false" id="WebPartWPQ1" width="100%" allowdelete="false" style=""><div id="DSM_Breadcrumbs" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><script>top.document.title ="APA DSM-5 |  B 08 Schizophrenia"</script><span><a class="DSM_bcNode" href="/">Home</a></span><span class="DSM_bcSeparator"> / </span><span><a class="DSM_bcNode" title="Proposed Revisions" href="../../proposedrevision/Pages/Default.html">
				Proposed Revisions
			</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcNode"><a target="_self" href="../../proposedrevision/Pages/SchizophreniaSpectrumandOtherPsychoticDisorders.html">Schizophrenia Spectrum and Other Psychotic Disorders</a></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcNode"></span><span class="DSM_bcSeparator"> / </span><span class="DSM_bcCurrent"> B 08 Schizophrenia</span></div><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table><div class="ms-PartSpacingVertical"></div></td>
	</tr><tr>
		<td id="MSOZoneCell_WebPartWPQ2" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="c31544f0-05e5-4027-985a-b5882502a9eb" haspers="false" id="WebPartWPQ2" width="100%" allowdelete="false" style=""><table border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr><td><table border="0" cellspacing="0" width="100%"><tr><td><h1><span><br>B 08 Schizophrenia</span></h1><div class="DSM_TabBar"><ul><li><a href="#" id="DSM_Tab_Proposed" class="DSM_TabOn" onclick="TabClick('Proposed','Rationale','Severity','DSM-IV')">Proposed   
								&nbsp;Revision</a></li><li><a href="#" id="DSM_Tab_Rationale" class="DSM_TabOff" onclick="TabClick('Rationale','Proposed','Severity','DSM-IV')">Rationale</a></li><li><a href="#" id="DSM_Tab_Severity" class="DSM_TabOff" onclick="TabClick('Severity','Proposed','Rationale','DSM-IV')">Severity</a></li><li><a href="#" id="DSM_Tab_DSM-IV" class="DSM_TabOff" onclick="TabClick('DSM-IV','Proposed','Rationale','Severity')">DSM-IV</a></li></ul><div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="0" height="0" alt=""></div></div><div id="DSM_TabContent_Proposed"><p class="MsoNormal" align="left"><span><font size="2" face="Arial"><span><span><span><font face="Arial"><font size="2"><span><strong>SCHIZOPHRENIA</strong></span></font></font></span></span></span></font></span></p>
<p class="MsoNormal" align="right"><span><font size="2" face="Arial"><span><em><span>Updated April 30, 2012</span></em></span></font></span></p>
<p class="MsoNormal" align="right"><span><font size="2" face="Arial"><span><em><span></span></em></span></font></span><span style="color:black"><span><font size="2" face="Arial">  </p>
<p style="line-height:normal;text-indent:-13.5pt;margin:0in 0in 6pt 13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">A. Two (or more) of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated).<span>  </span>At least one of these should include 1, 2, or 3.</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 27pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">(1) delusions</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 27pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">(2) hallucinations</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 27pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">(3) disorganized speech </span></p>
<p style="line-height:normal;margin:0in 0in 6pt 27pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">(4) grossly abnormal psychomotor behavior, including catatonia</span></p>
<p style="line-height:normal;margin:0in 0in 6pt 27pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">(5) negative symptoms, e.g., diminished emotional expression or avolition </span></p>
<p style="line-height:normal;margin:0in 0in 6pt 27pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-13.5pt;margin:0in 0in 6pt 13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">B. For a significant portion of the time since the onset of the disturbance, one or more major areas of functioning, such as school, work, interpersonal relations, or self-care, are markedly below the level achieved prior to the onset (or when the onset is in childhood or adolescence, failure to achieve expected level of interpersonal, academic, or occupational achievement).</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-13.5pt;margin:0in 0in 6pt 13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">C. Continuous signs of the disturbance persist for at least 6 months. This 6-month period must include at least 1 month of symptoms (or less if successfully treated) that meet Criterion A (i.e., active-phase symptoms) and may include periods of prodromal or residual symptoms. During these prodromal or residual periods, the signs of the disturbance may be manifested by only negative symptoms or by an attenuated form of two or more symptoms listed in Criterion A (e.g., beliefs perceived as odd, perceptual experiences described as out of the ordinary).</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-13.5pt;margin:0in 0in 6pt 13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">D. Schizoaffective Disorder and Depressive or Bipolar Disorder With Psychotic Features have been ruled out because either (1) no Major Depressive, Manic, or Mixed Episodes have occurred concurrently with the active-phase symptoms; or (2) if mood episodes have occurred during active-phase symptoms, their total duration has been less than half of the total duration of the active periods.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-13.5pt;margin:0in 0in 6pt 13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">E. The disturbance is not due to the direct physiological effects of a substance (e.g., an abused drug, a medication) or a general medical condition.</span></p>
<p style="line-height:normal;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="line-height:normal;text-indent:-13.5pt;margin:0in 0in 6pt 13.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">F. If there is a history of Autistic Disorder or another Pervasive Developmental Disorder or other communication disorder of childhood onset, the additional diagnosis of Schizophrenia is made only if prominent delusions or hallucinations are also present for at least 1 month (or less if successfully treated).</span></p>
<p class="MsoNormal"></font></span></span> </p>
<p style="line-height:200%;margin-bottom:0pt;tab-stops:1.0in" class="MsoNormal"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt"><em>Specify if:</em></span></span></p>
<p style="line-height:200%;margin-bottom:0pt;tab-stops:1.0in" class="MsoNormal"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt"><strong><a title="" href="../../proposedrevision/Pages/proposedrevision_rid_445.html" target="_blank"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt"><span style="line-height:200%;font-family:'arial','sans-serif';font-size:10pt"><strong>With <u>Catatonic Features</u></strong></span></span></a></strong></span></span></p>
<p class="MsoNormal"> </p></div><div id="DSM_TabContent_Rationale">  
<p style="text-align:center;margin-bottom:6pt" class="MsoNormal" align="center"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Schizophrenia in DSM-5</span></b></p>
<p style="margin-bottom:6pt" class="MsoNormal" align="right"><span style="font-family:'arial','sans-serif';font-size:10pt"><span><em>Updated May 14, 2012 </em></span></span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"><span></span>Introduction</span></b></p>
<p style="margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></b></p>
<p style="margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt"><span>            </span></span></b><span style="font-family:'arial','sans-serif';font-size:10pt">The DSM-IV definition of schizophrenia<b> </b>has been found to be clinically useful, have high reliability, and fair validity. Its validity is supported by a range of antecedent (familial aggregation, environmental risk factors),<sup> </sup>and predictive (diagnostic stability, course of illness, treatment response) validators; concurrent validation (eg., biological markers) is less robust. DSM-IV schizophrenia has very high diagnostic stability, with approximately 90 percent of individuals receiving an initial diagnosis of schizophrenia retaining that diagnosis at 1-10 years.<sup> </sup>Therefore, the core of the DSM-IV diagnostic criteria for schizophrenia will be retained, with modest changes proposed principally for the purpose of simplicity and clarification. The heterogeneity of schizophrenia, however, is now better understood in terms of distinct psychopathology dimensions rather than the classic subtypes; these subtypes provide a poor description of the enormous heterogeneity of this condition, have low diagnostic stability, and only the paranoid and undifferentiated subtypes are utilized with any frequency. As a result, we propose deletion of the current schizophrenia subtypes.</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Proposed Changes</span></b></p>
<p style="text-indent:31.7pt;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">We propose five specific changes in the diagnostic treatment of schizophrenia. The first four are principally for the purpose of enhancing simplicity and clarification. The fifth recommended change is more significant in that it proposes the deletion of the classic schizophrenia subtypes. All recommended changes will improve concordance with ICD-11 (based on the most recent draft version of ICD-11).</span></p>
<p style="text-indent:31.7pt;margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpFirst"><a name="OLE_LINK3"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">   </span></span></span><u><span style="font-family:'arial','sans-serif';font-size:10pt">Elimination of special treatment of bizarre delusions and special hallucinations in criterion A</span></u></a><span><span style="font-family:'arial','sans-serif';font-size:10pt"> (characteristic symptoms).<span>  </span>In </span></span><span style="font-family:'arial','sans-serif';font-size:10pt">DSM-IV, only one characteristic symptom is required if it is a bizarre delusion or special (‘Schneiderian first-rank’) hallucination. <b>The note asserting this special treatment will be deleted in DSM-5</b>. Bizarre delusions and Schneiderian first-rank symptoms are not found to have diagnostic specificity and these ‘positive symptoms’ will be treated like any other with regard to their diagnostic implication- as with other characteristic symptoms, two criterion A symptoms would need to be present for a diagnosis of schizophrenia. </span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt">This recommendation represents a continuation of the change begun in DSM-IV. In DSM-III, Schneiderian first-rank symptoms received particular prominence in the diagnosis of schizophrenia;<span>  </span>instead of two characteristic symptoms required to meet criterion A for schizophrenia, just one characteristic symptom was required if that symptom happened to be a Schneiderian first-rank symptom. This special treatment of Schneiderian first-rank symptoms (which overlap with the construct of bizarre delusions and “special” hallucinations) led to criterion A becoming excessively complex and redundant in DSM-III-R. In DSM-III-R, there were three separate criteria A (A1[two or more characteristic symptoms], A2 [bizarre delusions], and A3 [special types of hallucinations- Schneiderian first-rank hallucinations]) – the DSM-IV review found this to be unnecessarily complicated. In DSM-IV, it was decided to retain criterion A2 while folding the A3 criterion into A2 in DSM-IV. In DSM-IV, criterion A2 is stated as a criterion A note which reads: “Only one Criterion A symptom is required if delusions are bizarre or hallucinations consist of a voice keeping up a running commentary on the person’s thoughts, or two or more voices conversing with each other.” <b>This is the note whose deletion we propose for DSM-5.</b><a name="OLE_LINK5"></a><a name="OLE_LINK4"><span></span></a></span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpMiddle"><span><span><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></span></span></p>
<p style="margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpMiddle"><span><span><span style="font-family:'arial','sans-serif';font-size:10pt">A number of studies since 1994 have called into question the continued emphasis on bizarre delusions </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">and special hallucinations (Schneiderian FRS) in the definition of schizophrenia. First, the presence of first-rank symptoms in a mixed group of psychotic disorders is found to have no prognostic relevance or association with a family history of schizophrenia. Second, the reliability of bizarre delusions has been found to be poor. This proposed change will have a very limited impact on caseness, with about 2 percent of persons diagnosed with DSM-IV schizophrenia no longer meeting DSM-5 criteria for schizophrenia. In addition to improved reliability and criterion validity, this change will simplify criterion A for schizophrenia and thereby enhance clinical utility. This change will necessitate a change in the criteria for delusional disorder (allowing all delusions instead of just non-bizarre delusions); the use of a specifier for bizarre delusion will permit tracking of these individuals and thereby allow continuity with DSM-IV. Information about Schneiderian first-rank symptoms and discussion of bizarre delusions will be provided in the text.<span>      </span></span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoListParagraphCxSpLast"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">   </span></span></span><u><span style="font-family:'arial','sans-serif';font-size:10pt">Clarification of negative symptoms in criterion A</span></u><span style="font-family:'arial','sans-serif';font-size:10pt">. Restricted affect better describes the nature of affective abnormality in schizophrenia than affective flattening, and avolition/asociality and restricted affect better describe distinguishable aspects of negative symptoms of schizophrenia. Therefore, the fifth characteristic symptom in criterion A will now be listed as <u>negative symptoms, i.e., restricted affect or avolition/asociality</u> (changed from the DSM-IV negative symptoms, i.e., affective flattening, alogia, or avolition). This change is more in the nature of clarification and more accurate clinical description and should have no impact on caseness. </span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>3.<span style="font:7pt 'times new roman'">   </span></span></span><u><span style="font-family:'arial','sans-serif';font-size:10pt">Requirement that at least one of two required symptoms to meet criterion A be delusions, hallucinations, or disorganized speech</span></u><span style="font-family:'arial','sans-serif';font-size:10pt">.<span>  </span>These are core “positive symptoms” diagnosed with high reliability and might reasonably be considered necessary for a reliable diagnosis of schizophrenia. This should not affect caseness as one of these symptoms is present in all cases of DSM-IV schizophrenia across various datasets. </span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>4.<span style="font:7pt 'times new roman'">   </span></span></span><u><span style="font-family:'arial','sans-serif';font-size:10pt">Clarification of criterion F (Relationship to a pervasive developmental disorder)</span></u><span style="font-family:'arial','sans-serif';font-size:10pt">. Currently, if there is a history of autistic disorder or pervasive developmental disorder, the additional diagnosis of schizophrenia can only be made if prominent delusions or hallucinations are also present. There are other communication disorders of childhood onset, however, where disorganized speech and negative symptoms can be part of the presentation, necessitating the same specification. Consequently, criterion F will be restated as “If there is a history of autistic disorder, other pervasive developmental disorder, <u>or other communication disorder of childhood onset</u>, the additional diagnosis of schizophrenia is made only if prominent hallucinations or delusions are also present for at least a month (or less if successfully treated).” </span></p>
<p style="text-indent:-13.5pt;margin:0in 0in 6pt 22.5pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>5.<span style="font:7pt 'times new roman'">   </span></span></span><u><span style="font-family:'arial','sans-serif';font-size:10pt">Deletion of Subtypes</span></u><span style="font-family:'arial','sans-serif';font-size:10pt">. The current classic subtypes of schizophrenia provide a poor description of the heterogeneity of schizophrenia, have low diagnostic stability, do not exhibit distinctive patterns of treatment response or longitudinal course, and are not heritable. Except for the paranoid and undifferentiated subtypes, other subtypes are rarely diagnosed.<sup> </sup><span> </span>As a result, it is proposed that these subtypes of schizophrenia be eliminated from DSM-5. </span></p>
<p style="margin:0in 0in 6pt" class="MsoListParagraph"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">Since the inception of the concept of schizophrenia over a century ago, the heterogeneity of schizophrenia has been nosologically explained in terms of distinct clinical subtypes- disorganized (hebephrenic), catatonic, paranoid, and undifferentiated. Although these subtypes were recognized as having poor reliability, low stability over time, and negligible prognostic value during the DSM-IV process, it was decided to retain these subtypes “because of the substantial clinical tradition”. Recognizing that patients often present with more than one subtype and noting the very infrequent use of the disorganized and catatonic subtypes, DSM-IV introduced a hierarchical structure to indicate which subtype should take precedence. According to DSM-IV, the catatonic subtype was to be diagnosed even when the person had symptoms of the paranoid and disorganized subtypes; the disorganized subtype was to be diagnosed even when the person had symptoms of the paranoid subtype; and the undifferentiated subtype was to be diagnosed only when the person failed to have symptoms of the catatonic, disorganized, or paranoid subtypes.</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">A number of studies since 1994 have called into question the continued utilization of the classic subtypes of schizophrenia. Similar to findings of prior studies, cluster analytic and other approaches to identify taxonic schizophrenia subtypes consistently fail to identify the DSM-IV subtypes. A review of 24 publications describing 38 analyses of 28 participant cohorts found no support for classic schizophrenia subtypes. Subtypes continue to be found to exhibit poor diagnostic stability over time, do not cluster in families, and have limited prognostic value. Despite the introduction of a subtyping hierarchy in DSM-IV with the catatonic and disorganized subtypes at the apex of the hierarchy, these subtypes are still very rarely diagnosed. Administrative psychiatric practice data in the USA reveal that the catatonic subtype is applied to just 1 percent of all Medicaid recipients and 2 percent of general outpatients with a diagnosis of schizophrenia. Similarly, the disorganized subtype is applied to 2 percent of Medicaid recipients and 3 percent of general outpatients with a diagnosis of schizophrenia. In a large sample of 19,000 hospitalized psychiatric patients in China over a 10-year period with a diagnosis of schizophrenia, the catatonic subtype was diagnosed in 0.2 percent of patients and the disorganized subtype was applied in 1.0 percent of patients; in that sample, 91 percent of the schizophrenia patients received a diagnosis of the <i>undifferentiated</i> subtype. </span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">In view of their poor reliability, low diagnostic stability over time, absence of antecedent or concurrent validity, and negligible predictive validity, it is proposed that the DSM-IV subtypes of schizophrenia be eliminated. Since these subtypes have little clinical utility and except for the paranoid and undifferentiated subtypes, the other subtypes are rarely utilized in most mental healthcare systems, this change should have little effect on routine clinical practice. Furthermore, the use of psychopathological dimensions of psychosis in DSM-5 makes redundant the use of schizophrenia subtypes. As a contrast to subtyping, the use of psychopathological dimensions in DSM-5 should substantially improve the ability to describe the heterogeneity of schizophrenia in a manner that is more valid and clinically useful and additionally allows for changes over time.<u><br style="page-break-before:always" clear="all"></u></span></p>
<p style="margin:0in 0in 6pt" class="MsoListParagraph"><u><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="text-decoration:none"> </span></span></u></p>
<table style="border-bottom:medium none;border-left:medium none;width:660px;border-collapse:collapse;height:525px;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="660">
<tbody>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:531.9pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="887">
<p style="margin-bottom:6pt" class="MsoNormal"><b><span style="font-family:'arial','sans-serif';font-size:10pt">Proposed Criteria for Schizophrenia in DSM-5</span></b></p></td></tr>
<tr style="height:17.5pt">
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;padding-left:5.4pt;width:531.9pt;padding-right:5.4pt;height:17.5pt;border-top:medium none;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="887">
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">A. Characteristic symptoms: Two (or more) of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated). At least one of these should include 1-3 </span></p>
<p style="text-indent:-26.25pt;margin:0in 0in 6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Delusions</span></p>
<p style="text-indent:-26.25pt;margin:0in 0in 6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">          </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Hallucinations</span></p>
<p style="text-indent:-0.25in;margin-bottom:6pt;tab-stops:list .75in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">3.      Disorganized speech</span></p>
<p style="text-indent:-0.25in;margin-bottom:6pt;tab-stops:list .75in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">4.      Grossly abnormal psychomotor behavior, such as catatonia</span></p>
<p style="text-indent:-0.25in;margin-bottom:6pt;tab-stops:list .75in" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">5<b>.</b>      Negative symptoms, i.e., restricted affect or avolition/asociality</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">B. Social/occupational dysfunction: For a significant portion of the time since the onset of the disturbance, one or more major areas of functioning such as work, interpersonal relations, or self-care are markedly below the level achieved prior to the onset (or when the onset is in childhood or adolescence, failure to achieve expected level of interpersonal, academic, or occupational achievement).</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">C. Duration: Continuous signs of the disturbance persist for at least 6 months. This 6-month period must include at least 1 month of symptoms (or less if successfully treated) that meet Criterion A (i.e., active-phase symptoms) and may include periods of prodromal or residual symptoms. During these prodromal/residual periods, the signs of the disturbance may be manifested by only negative symptoms or two or more symptoms listed in Criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual experiences).</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">D. Schizoaffective and Mood Disorder exclusion: Schizoaffective Disorder and Mood Disorder With Psychotic Features have been ruled out because either (1) no Major Depressive or Manic Episodes have occurred concurrently with the active phase symptoms; or (2) if mood episodes have occurred during active-phase symptoms, their total duration has been brief relative to the duration of the active and residual periods.</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">E. Substance/general medical condition exclusion: The disturbance is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition.</span></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt">F. Relationship to a Pervasive Developmental Disorder: If there is a history of Autistic Disorder, another Pervasive Developmental Disorder, or other communication disorder of childhood onset, the additional diagnosis of Schizophrenia is made only if prominent delusions or hallucinations are also present for at least a month (or less if successfully treated). </span></p></td></tr></tbody></table>
<p style="margin-bottom:6pt" class="MsoNormal"><u><span style="font-family:'arial','sans-serif';font-size:10pt"><span style="text-decoration:none"> </span></span></u></p>
<p style="margin-bottom:6pt" class="MsoNormal"><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpFirst"><b><span style="font-family:'arial','sans-serif';font-size:10pt">References</span></b></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in" class="MsoListParagraphCxSpMiddle"><i><span style="font-family:'arial','sans-serif';font-size:10pt"> </span></i></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>1.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">American Psychiatric Association, 1994. <i><u>Diagnostic and Statistical Manual of Mental Disorders- 4<sup>th</sup> edition (DSM-IV)</u></i>. American Psychiatric Association, Washington D.C.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>2.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Schwartz JE, Fennig S, Tanenberg-Karant M, et al., 2000. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. <i><u>Arch. Gen. Psychiatry</u></i>, 57:593-600.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>3.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Forrester A, Owens DG, Johnstone EC, 2001. Diagnostic stability in subjects with multiple admissions for psychotic illness. <i><u>Psychol Med</u></i>, 31:151-158.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>4.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Amini H, Alaghband J, Omid A, et al., 2005. Diagnostic stability in patients with first-episode diagnosis. <i><u>Australas Psychiatry</u></i>, 13:388-392.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>5.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Haahr U, Friis S, Larsen TK, et al., 2008. First-episode psychosis: diagnostic stability over one and two years. <i><u>Psychopathology</u></i>, 41:322-329.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>6.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Chang WC, Chan SSM, Chung DWS, 2009. Diagnostic stability of functional psychosis: a systematic review. <i><u>Hong Kong J. Psychiatry</u></i>, 19:30-41.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>7.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Bromet EJ, Kotov R, Fochtmann LJ, et al., 2011. Diagnostic shifts during the decade following first admission for psychosis. <i><u>Am J Psychiatry</u></i>, 168:1186-1194.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>8.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Flaum M, Andreasen NC, Widiger TA, 1998. Schizophrenia and other psychotic disorders in DSM-IV: Final overview. In Widiger TA, Frances AJ, Pincus HA, et al. (Eds), <i><u>DSM-IV Sourcebook, Volume 4</u></i>. American Psychiatric Association, Washington D.C., pp 1007-1017.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>9.<span style="font:7pt 'times new roman'">      </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Tandon R, Nasrallah HA, Keshavan MS, 2009. Schizophrenia, “Just the Facts”. Part 4. Clinical features and concept<i><u>. Schizophr Res</u></i>, 110:1-23.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>10.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Goldman D, Hien DA, Haas GL, et al., 1992. Bizarre delusions and DSM-III-R schizophrenia. <i><u>Am J Psychiatry</u></i>, 149:494-499.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>11.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Tannenberg-Karant M, Fennig S, Ram R, et al., 1995. Bizarre delusions and first-rank symptoms in a first-admission sample: A preliminary analysis of prevalence and correlates. <i><u>Compr Psychiatry</u></i>, 36:428-434.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>12.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Peralta V, Cuesta MJ, 1999. Diagnostic significance of Schneider’s first-rank symptoms in schizophrenia. Comparative study between schizophrenic and nonschizophrenic psychotic disorders. <i><u>Br J Psychiatry</u></i>, 174:243-248. </span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>13.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Jansson LB, Parnas J, 2007. Competing definitions of schizophrenia: What can be learned from polydiagnostic studies? <i><u>Schizophr Bull</u></i>, 33:1178-1200.<b> </b></span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>14.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Nordgaard J, Arnfred SM, Handest P, et al., 2008. The diagnostic status of first-rank symptoms. <i><u>Schizophr Bull</u></i>, 34:137-154. </span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>15.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Mojtabai R, Nicholson RA, 1995. Inter-rater reliability of ratings of delusions and bizarre delusions<i><u>. Am J Psychiatry</u></i>, 152:1804-1806.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>16.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Mullen R, 2003. The problem of bizarre delusions<i><u>. J Nerv Ment Dis</u></i>, 191:546-548.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>17.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Bell V, Halligan PW, Ellis HD, 2006. Diagnosing delusions: a review of inter-rater reliability. <i><u>Schizophr Res</u></i>, 86:76-79.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>18.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Cohen AS, Junginger J, 2006. A three-dimensional typology of delusions. <i><u>Schizophr Res</u></i>, 83: 293-295.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>19.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Cermolacce M, Sass L, Parnas J, 2010. What is bizarre about bizarre delusions? A critical review. <i><u>Schizophr Bull</u></i>, 36:667-679.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>20.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Messinger JW, Tremeau F, Antonius D, et al., 2011. Avolition and expressive deficits capture negative symptom phenomenology: Implications for schizophrenia research. <i><u>Clinical Psychology Review</u></i>, 31:161-168.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>21.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Stompe T, Ortwein-Swoboda G, Ritter K, et al., 2002. Are we witnessing the disappearance of catatonic schizophrenia? <i><u>Compr Psychiatry</u></i>, 43:167-174.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>22.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Farmer AE, McGuffin P, Spitznagel EL, 1983. Clinical subtypes of schizophrenic disorders: a cluster analytic approach. <i><u>Psychiatry Res</u></i>, 8:1-12.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>23.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Dollfus S, Everitt B, Ribeyre JM, et al., 1996. Identifying subtypes of schizophrenia by cluster analysis. <i><u>Schizophr Bull</u></i>, 22:545-555.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>24.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Lykouras L, Oulis P, Daskalopolou E, et al., 2001. Clinical subtypes of schizophrenic disorders: a cluster analytic study. <i><u>Psychopathology</u></i>, 34:23-28.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>25.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Peralta V, Cuesta MJ, 2003. The nosology of psychotic disorders: A comparison among competing classification systems. <i><u>Schizophr Bull</u></i>,29:413-425.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>26.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Murray V, McKee I, Miller PM, et al., 2005. Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses. <i><u>Psychol Med</u></i>, 35:499-510.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>27.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Linscott RJ, Allardyce J, van Os J, 2010. Seeking verisimilitude in a class: A systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. <i><u>Schizophr Bull</u></i>, 36:811-829. </span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>28.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Carpenter, W.T., Bartko, J.J., Carpenter, C.L., Strauss, J.S., 1976. Another view of schizophrenia subtypes: A report from the International Pilot Study of schizophrenia. <i><u>Arch. Gen. Psychiatry</u></i> 33, 508-516.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>29.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Helmes E, Landmark J, 2003. Subtypes of schizophrenia: a cluster analytic approach. <i><u>Can J Psychiatry</u></i> 48, 702-708. </span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpMiddle"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>30.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">McGlashan TH, Fenton WS, 1994. Classical subtypes of schizophrenia. In <i><u>DSM-IV Sourcebook, Volume 1</u></i>, Edited by Widiger TA, Frances AJ, Pincus HA, et al.<span>  </span>American Psychiatric Association, Washington D.C., pp 419-440.</span></p>
<p style="text-indent:-0.25in;margin:0in 0in 6pt 0.25in;tab-stops:.5in" class="MsoListParagraphCxSpLast"><span style="font-family:'arial','sans-serif';font-size:10pt"><span>31.<span style="font:7pt 'times new roman'">   </span></span></span><span style="font-family:'arial','sans-serif';font-size:10pt">Xu TY, 2011. The subtypes of schizophrenia. <i><u>Shanghai Archives of Psychiatry</u></i>, 23:106-108.</span></p></div><div id="DSM_TabContent_Severity"><div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField">
<div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField"><span><span><font size="2" face="Arial">
<div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField">
<div style="display:inline" id="ctl00_m_g_f7094959_4272_49f5_a3fd_5fec8167517e_ctl00_ctl04_ctl04_ctl00_ctl00_ctl05_ctl00__ControlWrapper_RichHtmlField">
<p align="right"><span><font size="2" face="Arial">Updated April 30, 2012</font></span></p>
<p align="left"><span><font size="2" face="Arial">Dimensions will be assessed on a 0-4 scale cross-sectionally, with severity assessment based on past month. <span><font size="2"><font face="Arial">There are distinct psychopathological domains in psychotic illnesses (most clearly noted in schizophrenia) with distinctive patterns of treatment-response, prognostic implications, and course. The relative severity of symptoms across these domains varies across the course of illness and among patients. This is a ma<span>jor change that will potentially be of great clinical value and will also be of additional research utility.</span></font></font></span></font></p>
<p style="text-justify:inter-ideograph;text-align:justify;tab-stops:list .5in" class="MsoNormal" align="left"><font size="2" face="Arial">  </p>
<p style="text-justify:inter-ideograph;text-align:justify;tab-stops:list .5in" class="MsoNormal" align="left"></p>
<table style="border-bottom:medium none;border-left:medium none;width:724px;border-collapse:collapse;height:932px;border-top:medium none;border-right:medium none" class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="29">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-size:9pt"><font color="#000000" face="Times New Roman"></font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Hallucinations</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Delusions</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:76.05pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="127">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Disorganized Speech</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000"><strong>Abnormal Psychomotor Behavior</strong></font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Negative Symptoms (Restricted Emotional Expression or Avolition)</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.25in;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="150">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Impaired Cognition</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Depression</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:67.5pt;padding-right:5.4pt;border-top:windowtext 1pt solid;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="113">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><b><span style="font-family:'Arial','sans-serif';font-size:9pt">Mania</span></b><b><span style="font-family:'Times','serif';font-size:9pt"></span></b></font></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="29">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">0</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:76.05pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="127">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.25in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="150">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:67.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="113">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Not Present</font></span></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="29">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">1</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Equivocal (severity or duration not sufficient to be considered psychosis)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Equivocal (severity or duration not sufficient to be considered psychosis)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:76.05pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="127">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Equivocal (severity or duration not sufficient to be considered disorganization)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Equivocal (severity or duration not sufficient to be considered abnormal psychomotor behavior)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Equivocal decrease in facial expressivity, prosody, gestures or self-initiated behavior</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.25in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="150">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Equivocal (cognitive function not clearly outside the range expected for age or SES, i.e., within 0.5 SD of mean)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Equivocal (Occasionally feels sad, down depressed or hopeless; </span><span style="font-family:'Arial','sans-serif';font-size:9pt">concerned about having failed someone or at something but not preoccupied)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:67.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="113">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Equivocal (</span><span style="font-family:'Arial','sans-serif';font-size:9pt">Occasional elevated, expansive or irritable mood or some restlessness)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="29">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">2</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present, but mild (little pressure to act upon voices, not very bothered by voices; delusions are not bizarre, or little pressure to act upon delusional beliefs, not very bothered by belief)</font></span></p>
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000"><span></span></font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present, but mild (delusions are not bizarre, or little pressure to act upon delusional beliefs, not very bothered by beliefs)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:76.05pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="127">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present, but mild (some difficulty following speech)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present, but mild (occasional abnormal or bizarre motor behavior or catatonia)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present, but mild decrease in facial expressivity, prosody, gestures or self-initiated behavior</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.25in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="150">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present, but mild (some reduction in cognitive function below expected for age and SES, b/w 0.5 and 1 SD from mean)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Present, but mild (</span><span style="font-family:'Arial','sans-serif';font-size:9pt">Frequent periods of feeling very sad, down, moderately depressed or hopeless; Concerned about having failed someone or at something with some preoccupation)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:67.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="113">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Present, but mild (</span><span style="font-family:'Arial','sans-serif';font-size:9pt">Frequent periods of somewhat elevated, expansive or irritable mood or restlessness)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="29">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">3</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and moderate (some pressure to respond to voices, or is somewhat bothered by voices)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and moderate (some pressure to act upon beliefs, or is somewhat bothered by beliefs)</font></span></p>
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000"></font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:76.05pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="127">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and moderate (speech often difficult to follow)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and moderate (frequent abnormal or bizarre motor behavior or catatonia)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and moderate decrease in facial expressivity, prosody, gestures or self-initiated behavior</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.25in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="150">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and moderate (clear reduction in cognitive function below expected for age and SES, b/w 1 and 2 SD from mean)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Present and moderate (</span><span style="font-family:'Arial','sans-serif';font-size:9pt">Frequent periods of deep depression or hopelessness; preoccupation with guilt, having done wrong)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:67.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="113">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Present and moderate (</span><span style="font-family:'Arial','sans-serif';font-size:9pt">Frequent periods of extensively elevated, expansive or irritable mood or restlessness)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td></tr>
<tr>
<td style="border-bottom:windowtext 1pt solid;border-left:windowtext 1pt solid;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:17.55pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="29">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">4</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and severe (severe pressure to respond to voices, or is very bothered by voices)</font></span></p>
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000"></font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.2in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="144">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and severe (severe pressure to act upon beliefs, or is very bothered by beliefs)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:76.05pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="127">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and severe (speech almost impossible to follow)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and severe (abnormal or bizarre motor behavior or catatonia almost constant)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:85.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="143">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and severe decrease in facial expressivity, prosody, gestures or self-initiated behavior</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:1.25in;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="150">
<p style="margin:0in 0in 0pt" class="MsoNormal"><span style="font-family:'Arial','sans-serif';font-size:9pt"><font color="#000000">Present and severe (severe reduction in cognitive function below expected for age and SES, &gt; 2 SD from mean)</font></span></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:81pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="135">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Present and severe (Deeply depressed or hopeless daily; </span><span style="font-family:'Arial','sans-serif';font-size:9pt">Delusional guilt or unreasonable self‑reproach grossly out of proportion to circumstances)</span><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></font></p></td>
<td style="border-bottom:windowtext 1pt solid;border-left:#f0f0f0;padding-bottom:0in;background-color:transparent;padding-left:5.4pt;width:67.5pt;padding-right:5.4pt;border-top:#f0f0f0;border-right:windowtext 1pt solid;padding-top:0in" valign="top" width="113">
<p style="margin:0in 0in 0pt" class="MsoNormal"><font color="#000000"><span style="font-family:'Arial','sans-serif';font-size:9pt">Present and severe (</span><span style="font-family:'Arial','sans-serif';font-size:9pt">Daily and extensively elevated, expansive or irritable mood or restlessness)</span></font><span style="font-family:'Arial','sans-serif';font-size:9pt"></span></p></td></tr></tbody></table>
<p></p></font>
<ol style="margin-top:0in" type="1">
<p align="left"><font size="2" face="Arial"> </font></p></ol>
<p align="left"></span><span><span><span><font size="2" face="Arial"><strong>Logic and Justification for Dimensional Assessment of Symptoms and</strong></font></span></p>
<p style="text-align:center;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial"><strong>Related Clinical Phenomena in Psychosis.</strong></font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>Work on the causes and treatment of schizophrenia and other psychotic disorders has long recognized the heterogeneity of the symptoms that can be displayed by individuals with psychosis.<span>  </span>In addition, researchers have increasingly emphasized the ways in which the severity of different symptoms of this illness can vary across individuals, and have provided evidence that the severity of such symptoms can predict other important aspects of the illness, such as the degree of cognitive and/or neurobiological deficits </span><span>(e.g., Barch et al. 2003; Barch et al. 2004; Delawalla et al. 2006; Kerns and Berenbaum 2002; Perlstein et al. 2003; Strauss et al. 1993)</span><span>.<span>  </span>Further, research has increasingly emphasized that the boundaries between nosological entities may not be as categorical as suggested by individuals such as Kraepelin </span><span>(Kraepelin 1971)</span><span>, and putative comorbidity of various disorders may reflect impairments in common dimensions of genetic variation, human behavior and neurobiological function </span><span>(Owen et al. 2007)</span><span>. As such, it is important to explicitly include dimensional assessments of the core symptoms of psychotic disorders to help us identify this important variability.<span>  </span>Thus, we propose to include dimensional assessments of all of the symptoms included as diagnostic indicators in Criterion A of the diagnostic criteria for schizophrenia.<span>  </span>This includes hallucinations, delusions, disorganization, abnormal motor behavior, restricted emotional expression, and avolition.<span>  </span>Each of these symptoms will be rated for their current severity (<u>most severe in the past month)</u> on a five-point scale ranging from 0 (Not Present) to 5 (Present and Severe).<span>  </span>A score of 2 or higher will be considered sufficient severity to fulfill a Criterion A diagnostic Indicator for Schizophrenia.<span>  </span>We believe that including these dimensional assessments will help diagnosticians make reliable decisions about the presence or absence of diagnostic phenomena and that it will help clinicians attend to the clinically meaningful variation in the severity of these symptoms, which will help with treatment planning, prognostic decision making, and research on pathophysiological mechanisms.<span>  </span></span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial">Hallucinations and Delusions</font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>One might question whether we could collapse some of the symptoms in to a single dimension.<span>  </span>For example, both hallucinations and delusions are considered to be evidence of impaired reality testing, and in theory we could collapse these into a single dimension of reality testing. However, a number of treatment approaches, such as cognitive behavioral therapy, focus on the treatment of hallucinations and delusions in somewhat different ways, and thus we feel it is important for clinicians to have a means by which to separately assess the severity of such symptoms separately and to be able to track change in each domain of symptom individually</span><span>(Addington and Mancuso 2009; Gleeson et al. 2009; Velligan 2009)</span><span>. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><font face="Arial"><span><font size="2">Restricted Emotional Expression and Avolition</font></span><span><font size="2"> </font></span></font></p>
<p style="text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>In addition, we felt it important to distinguish between two different domains of negative symptoms: 1) restricted emotional expression; and 2) avolition. </span><span>Exploratory and confirmatory factor analyses of symptom assessment scales such as the Schedule for the Assessments of Negative Symptoms (SANS) at the item level have overwhelmingly supported separate negative symptom factors for Flat Affect/Diminished Expression and Avolition/Asociality/Anhedonia.<sup>39, 90-97</sup> Factor analytic studies of the SDS have also supported two separate factors of Diminished Emotional Expression and Avolition.<sup>99, 100</sup> Additional support for a two-factor model of negative symptoms comes from replication of the finding across heterogeneous samples. Separate factors for Flat Affect/Diminished Expression and Avolition/Asociality/Anhedonia have been identified in heterogeneous groups of patients with any psychotic disorder<sup>93, 95, 97</sup> as well as schizophrenia spectrum patients<sup>34, 39, 90-92, 94, 96</sup> and deficit syndrome patients.<sup>99, 100</sup> Furthermore, these factors were found in patients on<sup>34, 94, 96, 99</sup> and off medication<sup>39</sup> and in first-episode<sup>92</sup> and chronic<sup>91</sup> patients. Separate factors for affective flattening and avolition appear to hold up cross-culturally. Factor analyses of data collected from patients in the United States,<sup>34, 39, 91, 94, 96, 99</sup> Canada,<sup>92</sup> Spain,<sup>95</sup> South Africa,<sup>90</sup> Australia,<sup>93</sup> and Japan,<sup>100</sup> all supported Flat Affect/Diminished Expression and Avolition/Asociality/Anhedonia as separate factors, providing further evidence for recognizing deficits in affect and volition as two distinct symptom domains in schizophrenia. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>A primary reason for asking clinicians to rate each of these types of negative symptoms separately is evidence that they may differentially predict factors such as clinical presentation</span><span>(Strauss et al. in submission)</span><span>, functional outcome</span><span>(Strauss et al. in submission; Tattan and Creed 2001)</span><span>, cognitive deficits </span><span>(Gur et al. 2006; Malaspina and Coleman 2003; Suslow et al. 1998)</span><span>, emotional deficits</span><span>(Gur et al. 2006; Henry et al. 2007)</span><span>, and neurobiological impairments</span><span>(Dichter et al. 2009; Dowd and Barch in press; Fahim et al. 2005; Gur et al. 2007; Waltz et al. 2009)</span><span>. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial">Cognitive Function</font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>In addition to including dimensional assessments of the criterial symptoms of psychosis, we feel it is also important to include dimensional assessments of other important clinical phenomena that are relevant to treatment planning and prognosis.<span>  </span>First, we propose to include a dimensional assessment of cognitive impairment.<span>  </span>There is ample evidence that a large percentage of individuals with schizophrenia and other psychotic disorders suffer from impairments in a range of cognitive domains </span><span>(e.g., Reichenberg et al. 2008)</span><span>, and growing evidence that the level of cognitive impairment predicts functional abilities (social, occupational, living status)</span><span> </span><span>(e.g., Cervellione et al. 2007; Green et al. 2004; Heinrichs et al. 2008b; McClure et al. 2007)</span><span>. </span></font></font></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>Despite the importance of cognition to understanding function in schizophrenia and other psychotic disorders, we do not propose to include cognitive deficits as a Criterion A symptom of schizophrenia or any other psychotic disorder.<span>  </span>This is because cognition may not be useful as differential diagnosis tool.<span>  </span>The profile of cognitive impairments in similar across the non-affective and affective psychosis </span><span>(Depp et al. 2007; Hill et al. 2004; Reichenberg et al. 2008; Schretlen et al. 2007; Smith et al. 2009)</span><span>, though the level of impairment may be greater in non-affective psychoses </span><span>(Depp et al. 2007; Hill et al. 2004; Krabbendam et al. 2005; Schretlen et al. 2007)</span><span>. </span><span>Perhaps one of the clearest examples of such a result was recently provided by Reichenberg and colleagues </span><span>(Reichenberg et al. 2008)</span><span>. These researchers compared individuals with consensus research diagnoses of schizophrenia, schizoaffective disorder, major depressive disorder with affective features and bipolar disorder with psychotic features.<span>  </span>The individuals with schizophrenia and schizoaffective disorder were overall more impaired than the individuals with psychotic mood disorders, and the prevalence of cognitive impairment was higher in schizophrenia and schizoaffective disorder by definitions that they examined.<span>  </span>However, the individuals within all four groups showed the same <i>relative</i> pattern of impairment across cognitive domains, with the greatest impairment in verbal memory, and the least impairment in visual processing general verbal ability. Depp et al provided another compelling example in their studying comparing individuals with schizophrenia, bipolar disorder and healthy controls </span><span>(Depp et al. 2007)</span><span>.<span>  </span>Unlike, Reichenberg et al., Depp found that the bipolar patients were as impaired as the schizophrenia patients on many of the tests.<span>  </span>Further, the profile of impairment was very similar across groups, with the most impairment in information processing speed for both groups, and the least impairment in crystallized IQ.<span>  </span>In addition, there is evidence that the factor structure of cognition is very similar across schizophrenia and bipolar disorder </span><span>(Czobor et al. 2007)</span><span>. There are of course some exceptions to these results, and some studies that have shown differences across psychotic disorders in the pattern or severity of cognitive impairment </span><span>(Heinrichs et al. 2008a)</span><span>. However, the wealth of data suggest that this separation is not sufficient to justify inclusion of cognition as a Criterion A symptom of schizophrenia.</span></font></font></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>Nonetheless, it remains clear that cognitive function is important for understanding functional status in schizophrenia </span><span>(Bowie et al. 2008; Green et al. 2000; Green et al. 2004)</span><span>, as well as other psychotic disorders, including bipolar disorder </span><span>(Gruber et al. 2008; Jaeger et al. 2007; Martinez-Aran et al. 2004; Tabares-Seisdedos et al. 2008)</span><span>, and<span>  </span>that cognitive </span><span>deficits are not well treated by current antipsychotic medications </span><span>(e.g., Keefe et al. 2007)</span><span>.<span>  </span>Thus, we have included a dimensional assessment of cognition because it is important to highlight the potential need for additional treatments specifically targeting cognitive remediation in schizophrenia and other psychotic disorders </span><span>(e.g., Marder 2006; Marder and Fenton 2004)</span><span>.<span>  </span>We will be recommending that it is optimal to obtain a formal neuropsychological assessment in individuals with psychosis to fully understand the nature and severity of their cognitive impairments.<span>  </span>However, should this not be possible, we will be recommending that at minimum, clinicians conduct a brief and easy to validity administer assessment of cognition such as one of the many variations of the Digit Symbol Substitution Test.<span>  </span>These measures are very brief (under 5 minutes), are highly reliable, and are strong predictors of the severity of cognitive impairments shown by individuals with schizophrenia on large batteries of cognitive tests </span><span>(Dickinson 2008; Dickinson et al. 2008; Dickinson et al. 2007)</span><span>. The growing research on other methods for assessing cognitive function (e.g., self-report, clinician interview) suggests that these methods do not provide valid assessments of objective cognition impairment or functional outcome in psychosis</span><span>(Green et al. 2008)</span><span> and thus these are not sufficient as a basis for assessing cognitive impairment in schizophrenia.</span></font></font></p>
<p style="text-align:justify;margin-top:6pt" class="MsoNormal" align="left"><span><font size="2" face="Arial">Depression and Mania</font></span></p>
<p style="text-align:justify;margin-top:6pt;text-indent:0.5in" class="MsoNormal" align="left"><font size="2"><font face="Arial"><span>We also propose to include dimensional assessments of depression and mania for all psychotic disorders.<span>  </span>There is growing evidence that schizoaffective disorder does not represent a distinct nosological category separate form schizophrenia </span><span>(e.g., Malhi et al. 2008; Owen et al. 2007; Peralta and Cuesta 2009)</span><span>. However, at the same time there is good evidence that the severity of the mood pathology present in individuals with schizophrenia indicates important information about prognosis and outcome </span><span>(Bowie et al. 2006; Crumlish et al. 2005)</span><span>, and the need for treatments specifically targeting these mood symptoms </span><span>(e.g., Addington et al. 1998; Peralta and Cuesta 2009)</span><span>.<span>  </span>Thus, dimensional assessments of depression and mania for all psychotic disorders will serve to alert clinicians to look for the presence of mood pathology and treat it were appropriate. <span> </span></span></font></font></p>
<p align="left"><span><font size="2" face="Arial"><strong>References</strong></font></span></p><font face="Arial"><font size="2">
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Addington, D.; Addington, J.; and Patten, S. Depression in people with first-episode schizophrenia. <i>Br J Psychiatry Suppl</i>, 172(33):90-2, 1998. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Addington, J., and Mancuso, E. Cognitive-behavioral therapy for individuals at high risk of developing psychosis. <i>J Clin Psychol</i>, 65(8):879-90, 2009. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Barch, D.M.; Carter, C.S.; and Cohen, J.D. Context processing deficit in schizophrenia:<span>  </span>Diagnostic specificity, 4-week course, and relationships to clinical symptoms. <i>Journal of Abnormal Psychology</i>, 112(132-143), 2003. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Barch, D.M.; Mitropoulou, V.; Harvey, P.D.; New, A.S.; Silverman, J.M.; and Siever, L.J. Context-processing deficits in schizotypal personality disorder. <i>Journal of Abnormal Psychology</i>, 113(4):556-68, 2004. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Bowie, C.R.; Leung, W.W.; Reichenberg, A.; McClure, M.M.; Patterson, T.L.; Heaton, R.K.; and Harvey, P.D. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. <i>Biol Psychiatry</i>, 63(5):505-11, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2"><font face="Arial">Bowie, C.R.; Reichenberg, A.; Patterson, T.L.; Heaton, R.K.; and Harvey, P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. <i>Am J Psychiatry</i>, 163(3):418-25, 2006. </font><font face="Arial">  </font></font></p>
<p class="MsoNormal"><font face="Arial"><font size="2"><span style="color:black">Carpenter WT, Buchanan RW.  Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia.  In: Schulz SC, Tamminga CT (eds.),  <i>Schizophrenia: Scientific Progress</i>.  Oxford University Press, New York, pp. 13-22, 1989.</span><span style="color:black"></span></font></font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font face="Arial"><font size="2"><span style="color:black">Carpenter WT, Heinrichs DW, Wagman AMI.  Deficit and non-deficit forms of schizophrenia: The concept.  <i>Am J Psychiatry 145:</i>578-583, 1988.</span><span style="color:black"></span></font></font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Cervellione, K.L.; Burdick, K.E.; Cottone, J.G.; Rhinewine, J.P.; and Kumra, S. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome. <i>Journal of the American Academy of Child and Adolescent Psychiatry</i>, 46(7):867-78, 2007.</font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Crumlish, N.; Whitty, P.; Kamali, M.; Clarke, M.; Browne, S.; McTigue, O.; Lane, A.; Kinsella, A.; Larkin, C.; and O'Callaghan, E. Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder. <i>Acta Psychiatr Scand</i>, 112(6):449-55, 2005. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Czobor, P.; Jaeger, J.; Berns, S.M.; Gonzalez, C.; and Loftus, S. Neuropsychological symptom dimensions in bipolar disorder and schizophrenia. <i>Bipolar Disord</i>, 9(1-2):71-92, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Delawalla, Z.; Barch, D.M.; Fisher Eastep, J.L.; Thomason, E.S.; Hanewinkel, M.J.; Thompson, P.A.; and Csernansky, J.G. Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. <i>Schizophrenia Bulletin</i>, 2006. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Depp, C.A.; Moore, D.J.; Sitzer, D.; Palmer, B.W.; Eyler, L.T.; Roesch, S.; Lebowitz, B.D.; and Jeste, D.V. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. <i>J Affect Disord</i>, 101(1-3):201-9, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dichter, G.S.; Bellion, C.; Casp, M.; and Belger, A. Impaired Modulation of Attention and Emotion in Schizophrenia. <i>Schizophr Bull</i>, 2009. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dickinson, D. Digit symbol coding and general cognitive ability in schizophrenia: worth another look? <i>Br J Psychiatry</i>, 193(5):354-6, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dickinson, D.; Ragland, J.D.; Gold, J.M.; and Gur, R.C. General and specific cognitive deficits in schizophrenia: Goliath defeats David? <i>Biol Psychiatry</i>, 64(9):823-7, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dickinson, D.; Ramsey, M.E.; and Gold, J.M. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. <i>Archives<span>  </span>of General Psychiatry</i>, 64(5):532-42, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Dowd, E., and Barch, D.M. Subjective emotional experience in schizophrenia:<span>  </span>Neural and behavioral markers. <i>Biological Psychiatry</i>, in press. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Fahim, C.; Stip, E.; Mancini-Marie, A.; Mensour, B.; Boulay, L.J.; Leroux, J.M.; Beaudoin, G.; Bourgouin, P.; and Beauregard, M. Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study. <i>Psychiatry Res</i>, 140(1):1-15, 2005. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gleeson, J.F.; Cotton, S.M.; Alvarez-Jimenez, M.; Wade, D.; Gee, D.; Crisp, K.; Pearce, T.; Newman, B.; Spiliotacopoulos, D.; Castle, D.; and McGorry, P.D. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. <i>J Clin Psychiatry</i>, 70(4):477-86, 2009. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Green, M.F.; Kern, R.S.; Braff, D.L.; and Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the &quot;right stuff&quot;? <i>Schizophrenia Bulletin Special Issue: Psychosocial treatment for schizophrenia</i>, 26(1):119-136, 2000. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Green, M.F.; Kern, R.S.; and Heaton, R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. <i>Schizophrenia Research</i>, 72(1):41-51, 2004. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Green, M.F.; Nuechterlein, K.H.; Kern, R.S.; Baade, L.E.; Fenton, W.S.; Gold, J.M.; Keefe, R.S.; Mesholam-Gately, R.; Seidman, L.J.; Stover, E.; and Marder, S.R. Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study. <i>Am J Psychiatry</i>, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gruber, S.A.; Rosso, I.M.; and Yurgelun-Todd, D. Neuropsychological performance predicts clinical recovery in bipolar patients. <i>J Affect Disord</i>, 105(1-3):253-60, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gur, R.E.; Kohler, C.G.; Ragland, J.D.; Siegel, S.J.; Lesko, K.; Bilker, W.B.; and Gur, R.C. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. <i>Schizophr Bull</i>, 32(2):279-87, 2006. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Gur, R.E.; Loughead, J.; Kohler, C.G.; Elliott, M.A.; Lesko, K.; Ruparel, K.; Wolf, D.H.; Bilker, W.B.; and Gur, R.C. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. <i>Arch Gen Psychiatry</i>, 64(12):1356-66, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Heinrichs, R.W.; Ammari, N.; McDermid Vaz, S.; and Miles, A.A. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable? <i>Schizophr Res</i>, 99(1-3):149-54, 2008a. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Heinrichs, R.W.; Goldberg, J.O.; Miles, A.A.; and McDermid Vaz, S. Predictors of medication competence in schizophrenia patients. <i>Psychiatry Research</i>, 157(1-3):47-52, 2008b. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Henry, J.D.; Green, M.J.; de Lucia, A.; Restuccia, C.; McDonald, S.; and O'Donnell, M. Emotion dysregulation in schizophrenia: reduced amplification of emotional expression is associated with emotional blunting. <i>Schizophr Res</i>, 95(1-3):197-204, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Hill, S.K.; Keshavan, M.S.; Thase, M.E.; and Sweeney, J.A. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. <i>Am J Psychiatry</i>, 161(6):996-1003, 2004. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Jaeger, J.; Berns, S.; Loftus, S.; Gonzalez, C.; and Czobor, P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. <i>Bipolar Disord</i>, 9(1-2):93-102, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Keefe, R.S.; Bilder, R.M.; Davis, S.M.; Harvey, P.D.; Palmer, B.W.; Gold, J.M.; Meltzer, H.Y.; Green, M.F.; Capuano, G.; Stroup, T.S.; McEvoy, J.P.; Swartz, M.S.; Rosenheck, R.A.; Perkins, D.O.; Davis, C.E.; Hsiao, J.K.; and Lieberman, J.A. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. <i>Archives of General<span>  </span>Psychiatry</i>, 64(6):633-47, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Kerns, J.B., and Berenbaum, H. Cognitive impairments associated with formal thought disorder in people with schizophrenia. <i>Journal of Abnormal Psychology</i>, 111(2):211-224, 2002. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Krabbendam, L.; Arts, B.; van Os, J.; and Aleman, A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. <i>Schizophr Res</i>, 80(2-3):137-49, 2005. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Kraepelin, E. <i>Dementia praecox and paraphrenia</i>. Edinburgh: Livingston (Original work published 1919), 1971. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Malaspina, D., and Coleman, E. Olfaction and social drive in schizophrenia. <i>Arch Gen Psychiatry</i>, 60(6):578-84, 2003. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Malhi, G.S.; Green, M.; Fagiolini, A.; Peselow, E.D.; and Kumari, V. Schizoaffective disorder:<span>  </span>Diagnostic issues and future recommendations. <i>Bipolar DIsorders</i>, 10:215-230, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Marder, S.R. Drug initiatives to improve cognitive function. <i>Journal of Clinical Neuropsychiatry</i>, 67 Suppl 9:31-5; discussion 36-42, 2006. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Marder, S.R., and Fenton, W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. <i>Schizophrenia Research</i>, 72(1):5-9, 2004. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Martinez-Aran, A.; Vieta, E.; Reinares, M.; Colom, F.; Torrent, C.; Sanchez-Moreno, J.; Benabarre, A.; Goikolea, J.M.; Comes, M.; and Salamero, M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. <i>Am J Psychiatry</i>, 161(2):262-70, 2004. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">McClure, M.M.; Bowie, C.R.; Patterson, T.L.; Heaton, R.K.; Weaver, C.; Anderson, H.; and Harvey, P.D. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? <i>Schizophr Res</i>, 89(1-3):330-8, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Owen, M.J.; Craddock, N.; and Jablensky, A. The genetic deconstruction of psychosis. <i>Schizophrenia Bulletin</i>, 33(4):905-911, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Peralta, V., and Cuesta, M.J. Exploring the borders of the schizoaffective spectrum:<span>  </span>A categorial and dimensional approach. <i>Journal of Affective Disorders</i>, 108:71-86, 2009. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Perlstein, W.M.; Dixit, N.K.; Carter, C.S.; Noll, D.C.; and Cohen, J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. <i>Biological Psychiatry</i>, 53:25-38, 2003. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Reichenberg, A.; Harvey, P.D.; Bowie, C.R.; Mojtabai, R.; Rabinowitz, J.; Heaton, R.K.; and Bromet, E. Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders. <i>Schizophr Bull</i>, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Schretlen, D.J.; Cascella, N.G.; Meyer, S.M.; Kingery, L.R.; Testa, S.M.; Munro, C.A.; Pulver, A.E.; Rivkin, P.; Rao, V.A.; Diaz-Asper, C.M.; Dickerson, F.B.; Yolken, R.H.; and Pearlson, G.D. Neuropsychological functioning in bipolar disorder and schizophrenia. <i>Biol Psychiatry</i>, 62(2):179-86, 2007. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Smith, M.J.; Barch, D.M.; and Csernansky, J.G. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology. <i>Schizophr Res</i>, 107(1):69-75, 2009. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Strauss, G.P.; Miski, P.; Fisher, B.A.; Kirkpatrick, B.; Buchanan, R.W.; and Carpenter, W.T. Deconstructing negative symptoms of schizophrenia: Avolition-apathy and emotional expression clusters predict clinical presentation and functional outcome. in submission. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Strauss, M.E.; Buchanan, R.W.; and Hale, J. Relations between attentional deficits and clinical symptoms in schizophrenic outpatients. <i>Psychiatry Research</i>, 47:205-213, 1993. </font></p>
<p class="MsoNormal"><font face="Arial"><font size="2"><span style="color:black">Strauss JS, Carpenter WT Jr, Bartko JJ. The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. <em>Schizophr Bull</em>. 1974 Winter;(11): 61-9.</span><span style="color:black"></span></font></font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2"><font face="Arial">Suslow, T.; Junghanns, K.; Weitzsch, C.; and Arolt, V. Relations between neuropsychological vulnerability markers and negative symptoms in schizophrenia. <i>Psychopathology</i>, 31(4):178-87, 1998.</font><font face="Arial"> </font></font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Tabares-Seisdedos, R.; Balanza-Martinez, V.; Sanchez-Moreno, J.; Martinez-Aran, A.; Salazar-Fraile, J.; Selva-Vera, G.; Rubio, C.; Mata, I.; Gomez-Beneyto, M.; and Vieta, E. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. <i>J Affect Disord</i>, 109(3):286-99, 2008. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Tattan, T.M., and Creed, F.H. Negative symptoms of schizophrenia and compliance with medication. <i>Schizophr Bull</i>, 27(1):149-55, 2001. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Velligan, D.I. Cognitive behavior therapy for psychosis: where have we been and where are we going? <i>Schizophr Bull</i>, 35(5):857-8, 2009. </font></p>
<p style="text-align:justify" class="MsoNormal" align="left"><font size="2" face="Arial">Waltz, J.A.; Schweitzer, J.B.; Gold, J.M.; Kurup, P.K.; Ross, T.J.; Salmeron, B.J.; Rose, E.J.; McClure, S.M.; and Stein, E.A. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. <i>Neuropsychopharmacology</i>, 34(6):1567-77, 2009.</font></p></font></font></span></span></div></div></font></span></span></div></div></div><div id="DSM_TabContent_DSM-IV"><font size="2" face="Arial"><span style="color:black"><strong>Schizophrenia</strong></span></font> 
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A. <i>Characteristic symptoms: </i>Two (or more) of the following, </font></span><span style="color:black"><font size="2" face="Arial">each present for a significant portion of time during a 1-month </font></span><span style="color:black"><font size="2" face="Arial">period (or less if successfully treated):</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(1) delusions</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(2) hallucinations</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(3) disorganized speech (e.g., frequent derailment or incoherence)</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(4) grossly disorganized or catatonic behavior</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(5) negative symptoms, i.e., affective flattening, alogia, or </font></span><span style="color:black"><font size="2" face="Arial">avolition</font></span></p>
<p class="MsoNormal"><font size="2"><span><font face="Arial"><strong>Note: </strong>Only one Criterion A symptom is required if delusions </font></span></font><span style="color:black"><font size="2" face="Arial">are bizarre or hallucinations consist of a voice keeping up a </font></span><span style="color:black"><font size="2" face="Arial">running commentary on the person's behavior or thoughts, or </font></span><span style="color:black"><font size="2" face="Arial">two or more voices conversing with each other.</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">B. <i>Social/occupational dysfunction: </i>For a significant portion of </font></span><span style="color:black"><font size="2" face="Arial">the time since the onset of the disturbance, one or more major </font></span><span style="color:black"><font size="2" face="Arial">areas of functioning such as work, interpersonal relations, </font></span><span style="color:black"><font size="2" face="Arial">or self-care are markedly below the level achieved prior to the </font></span><span style="color:black"><font size="2" face="Arial">onset (or when the onset is in childhood or adolescence, failure </font></span><span style="color:black"><font size="2" face="Arial">to achieve expected level of interpersonal, academic, or </font></span><span style="color:black"><font size="2" face="Arial">occupational achievement).</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">C. <i>Duration: </i>Continuous signs of the disturbance persist for at </font></span><span style="color:black"><font size="2" face="Arial">least 6 months. This 6-month period must include at least 1 </font></span><span style="color:black"><font size="2" face="Arial">month of symptoms (or less if successfully treated) that meet </font></span><span style="color:black"><font size="2" face="Arial">Criterion A (i.e., active-phase symptoms) and may include periods </font></span><span style="color:black"><font size="2" face="Arial">of prodromal or residual symptoms. During these prodromal </font></span><span style="color:black"><font size="2" face="Arial">or residual periods, the signs of the disturbance may </font></span><span style="color:black"><font size="2" face="Arial">be manifested by only negative symptoms or two or more </font></span><span style="color:black"><font size="2" face="Arial">symptoms listed in Criterion A present in an attenuated form </font></span><span style="color:black"><font size="2" face="Arial">(e.g., odd beliefs, unusual perceptual experiences).</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">D. <i>Schizoaffective and Mood Disorder exclusion: </i>Schizoaffective </font></span><span style="color:black"><font size="2" face="Arial">Disorder and Mood Disorder With Psychotic Features have </font></span><span style="color:black"><font size="2" face="Arial">been ruled out because either (1) no Major Depressive, Manic, </font></span><span style="color:black"><font size="2" face="Arial">or Mixed Episodes have occurred concurrently with the activephase </font></span><span style="color:black"><font size="2" face="Arial">symptoms; or (2) if mood episodes have occurred during </font></span><span style="color:black"><font size="2" face="Arial">active-phase symptoms, their total duration has been brief </font></span><span style="color:black"><font size="2" face="Arial">relative to the duration of the active and residual periods.</font></span></p>
<p class="MsoNormal"><span style="color:black"></span><span style="color:black"><font size="2" face="Arial">E. <i>Substance/general medical condition exclusion: </i>The disturbance </font></span><span style="color:black"><font size="2" face="Arial">is not due to the direct physiological effects of a substance </font></span><span style="color:black"><font size="2" face="Arial">(e.g., a drug of abuse, a medication) or a general </font></span><span style="color:black"><font size="2" face="Arial">medical condition.</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">F. <i>Relationship to a Pervasive Developmental Disorder: </i>If there </font></span><span style="color:black"><font size="2" face="Arial">is a history of Autistic Disorder or another Pervasive Developmental </font></span><span style="color:black"><font size="2" face="Arial">Disorder, the additional diagnosis of Schizophrenia is </font></span><span style="color:black"><font size="2" face="Arial">made only if prominent delusions or hallucinations are also </font></span><span style="color:black"><font size="2" face="Arial">present for at least a month (or less if successfully treated).</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">Schizophrenia Subtypes</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">The subtypes of Schizophrenia are defined by the predominant </font></span><span style="color:black"><font size="2" face="Arial">symptomatology at the time of evaluation.</font></span></p>
<p class="MsoNormal"><font size="2" face="Arial"><span><strong>295.30 Paranoid Type</strong></span></font></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A type of Schizophrenia in which the following criteria are met:</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A. Preoccupation with one or more delusions or frequent auditory </font></span><span style="color:black"><font size="2" face="Arial">hallucinations.</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">B. None of the following is prominent: disorganized speech, disorganized </font></span><span style="color:black"><font size="2" face="Arial">or catatonic behavior, or flat or inappropriate </font></span><span style="color:black"><font size="2" face="Arial">affect.</font></span></p>
<p class="MsoNormal"><span style="color:black"></span><font size="2" face="Arial"><span><strong>295.10 Disorganized Type</strong></span></font></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A type of Schizophrenia in which the following criteria are met:</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A. All of the following are prominent:</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(1) disorganized speech</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(2) disorganized behavior</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(3) flat or inappropriate affect</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">B. The criteria are not met for Catatonic Type.</font></span></p>
<p class="MsoNormal"><font size="2" face="Arial"><span><strong>295.20 Catatonic Type</strong></span></font></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A type of Schizophrenia in which the clinical picture is dominated </font></span><span style="color:black"><font size="2" face="Arial">by at least two of the following:</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(1) motoric immobility as evidenced by catalepsy (including waxy </font></span><span style="color:black"><font size="2" face="Arial">flexibility) or stupor</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(2) excessive motor activity (that is apparently purposeless and </font></span><span style="color:black"><font size="2" face="Arial">not influenced by external stimuli)</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(3) extreme negativism (an apparently motiveless resistance to </font></span><span style="color:black"><font size="2" face="Arial">all instructions or maintenance of a rigid posture against attempts </font></span><span style="color:black"><font size="2" face="Arial">to be moved) or mutism</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(4) peculiarities of voluntary movement as evidenced by posturing </font></span><span style="color:black"><font size="2" face="Arial">(voluntary assumption of inappropriate or bizarre postures), </font></span><span style="color:black"><font size="2" face="Arial">stereotyped movements, prominent mannerisms, or </font></span><span style="color:black"><font size="2" face="Arial">prominent grimacing</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">(5) echolalia or echopraxia</font></span></p>
<p class="MsoNormal"><font size="2" face="Arial"><span><strong>295.90 Undifferentiated Type</strong></span></font></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A type of Schizophrenia in which symptoms that meet Criterion </font></span><span style="color:black"><font size="2" face="Arial">A are present, but the criteria are not met for the Paranoid, Disorganized, </font></span><span style="color:black"><font size="2" face="Arial">or Catatonic Type.</font></span></p>
<p class="MsoNormal"><font size="2" face="Arial"><span><strong>295.60 Residual Type</strong></span></font></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">A type of Schizophrenia in which the following criteria are met: </font></span></p>
<p class="MsoNormal"><span style="color:black"></span><span style="color:black"><font size="2" face="Arial">A. Absence of prominent delusions, hallucinations, disorganized </font></span><span style="color:black"><font size="2" face="Arial">speech, and grossly disorganized or catatonic behavior.</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">B. There is continuing evidence of the disturbance, as indicated </font></span><span style="color:black"><font size="2" face="Arial">by the presence of negative symptoms or two or more symptoms </font></span><span style="color:black"><font size="2" face="Arial">listed in Criterion A for Schizophrenia, present in an </font></span><span style="color:black"><font size="2" face="Arial">attenuated form (e.g., odd beliefs, unusual perceptual experiences). </font></span></p>
<p class="MsoNormal"><span style="color:black"></span><span style="color:black"><font size="2" face="Arial">Classification of Longitudinal </font></span><span style="color:black"><font size="2" face="Arial">Course for Schizophrenia</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">These specifiers can be applied only after at least 1 year has </font></span><span style="color:black"><font size="2" face="Arial">elapsed since the initial onset of active-phase symptoms:</font></span></p>
<p class="MsoNormal"><font size="2"><span><font face="Arial"><strong>Episodic With Interepisode Residual Symptoms. </strong>This </font></span></font><span style="color:black"><font size="2" face="Arial">specifier applies when the course is characterized by episodes </font></span><span style="color:black"><font size="2" face="Arial">in which Criterion A for Schizophrenia is met and </font></span><span style="color:black"><font size="2" face="Arial">there are clinically significant residual symptoms between</font></span><span style="color:black"><font size="2" face="Arial">the episodes. <b>With Prominent Negative Symptoms </b>can </font></span><span style="color:black"><font size="2" face="Arial">be added if prominent negative symptoms are present </font></span><span style="color:black"><font size="2" face="Arial">during these residual periods.</font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial"><strong>Episodic With No Interepisode Residual Symptoms.</strong></font></span></p>
<p class="MsoNormal"><span style="color:black"><font size="2" face="Arial">This specifier applies when the course is characterized by </font></span><span style="color:black"><font size="2" face="Arial">episodes in which Criterion A for Schizophrenia is met </font></span><span style="color:black"><font size="2" face="Arial">and there are no clinically significant residual symptoms </font></span><span style="color:black"><font size="2" face="Arial">between the episodes.</font></span></p>
<p class="MsoNormal"><font size="2"><span><font face="Arial"><strong>Continuous. </strong>This specifier applies when characteristic </font></span></font><span style="color:black"><font size="2" face="Arial">symptoms of Criterion A are met throughout all (or most) </font></span><span style="color:black"><font size="2" face="Arial">of the course. <b>With Prominent Negative Symptoms </b>can </font></span><span style="color:black"><font size="2" face="Arial">be added if prominent negative symptoms are also </font></span><span style="color:black"><font size="2" face="Arial">present.</font></span></p>
<p class="MsoNormal"><font size="2"><span><font face="Arial"><strong>Single Episode In Partial Remission. </strong>This specifier applies </font></span></font><font face="Arial"><font size="2"><span style="color:black">when there has been a single episode in which Criter</span></font><span style="color:black"><font size="2">ion A for Schizophrenia is met and some clinically </font></span></font><span style="color:black"><font size="2"><font face="Arial">significant residual symptoms remain. <b>With Prominent </b></font></font></span><font size="2"><span><font face="Arial"><strong>Negative Symptoms </strong>can be added if these residual symptoms </font></span></font><span style="color:black"><font size="2" face="Arial">include prominent negative symptoms. </font></span></p>
<p class="MsoNormal"><span style="color:black"></span><font size="2"><span><font face="Arial"><strong>Single Episode In Full Remission. </strong>This specifier applies </font></span></font><span style="color:black"><font size="2" face="Arial">when there has been a single episode in which Criterion </font></span><span style="color:black"><font size="2" face="Arial">A for Schizophrenia has been met and no clinically </font></span><span style="color:black"><font size="2" face="Arial">significant residual symptoms remain.</font></span></p>
<p class="MsoNormal"><font size="2"><span><font face="Arial"><strong>Other or Unspecified Pattern. </strong>This specifier is used if </font></span></font><span style="color:black"><font size="2" face="Arial">another or an unspecified course pattern has been present.</font></span></p></div></td></tr></table></td></tr></table><table cellspacing="0" cellpadding="4" border="0" width="100%" xmlns:x="http://www.w3.org/2001/XMLSchema" xmlns:d="http://schemas.microsoft.com/sharepoint/dsp" xmlns:asp="http://schemas.microsoft.com/ASPNET/20" xmlns:__designer="http://schemas.microsoft.com/WebParts/v2/DataView/designer" xmlns:sharepoint="Microsoft.SharePoint.WebControls" xmlns:ddwrt2="urn:frontpage:internal"><tr></tr></table></div></td>
			</tr>
		</table><div class="ms-PartSpacingVertical"></div></td>
	</tr><tr>
		<td id="MSOZoneCell_WebPartWPQ4" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="f02ada8a-2400-4fe7-8d10-03411362e842" haspers="false" id="WebPartWPQ4" width="100%" class="ms-WPBody" allowdelete="false" style=""><script type="text/javascript">
$(document).ready(function() {
  TabClick('Proposed','Rationale','Severity','DSM-IV');
});
</script></div></td>
			</tr>
		</table></td>
	</tr>
</table>								
	</div>
	<div id="DSM_RightCol">
		<div id="DSM_int_topRight">	
		</div>
		<div id="DSM_int_btmRight">
			<div id="ctl00_PlaceHolderMain_ctl00__ControlWrapper_RichHtmlField" style="display:inline"></div>						
			<table width="100%" cellpadding="0" cellspacing="0" border="0">
	<tr>
		<td id="MSOZoneCell_WebPartWPQ3" valign="top"><table toplevel border="0" cellpadding="0" cellspacing="0" width="100%">
			<tr>
				<td valign="top"><div webpartid="3cf5e074-39b0-425f-92e8-f3c760a6ce71" haspers="false" id="WebPartWPQ3" width="100%" allowdelete="false" allowexport="false" style=""><table width="100%" cellspacing="0" cellpadding="0" border="0"><script>
ctx = new ContextInfo();
ctx.listBaseType = 0;
ctx.listTemplate = 103;
ctx.listName = "{59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}";
ctx.view = "{3CF5E074-39B0-425F-92E8-F3C760A6CE71}";
ctx.listUrlDir = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links";
ctx.HttpPath = "\u002fproposedrevision\u002f_vti_bin\u002fowssvr.dll?CS=65001";
ctx.HttpRoot = "https:\u002f\u002f\u002fweb\u002f20121020113826\u002fhttp:\u002f\u002fwww.dsm5.org\u002fproposedrevision";
ctx.imagesPath = "\u002f_layouts\u002fimages\u002f";
ctx.PortalUrl = "";
ctx.SendToLocationName = "";
ctx.SendToLocationUrl = "";
ctx.RecycleBinEnabled = -1;
ctx.OfficialFileName = "";
ctx.WriteSecurity = "1";
ctx.SiteTitle = "Proposed Revisions";
ctx.ListTitle = "Related Links";
if (ctx.PortalUrl == "") ctx.PortalUrl = null;
ctx.displayFormUrl = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links\u002fDispForm.aspx";
ctx.editFormUrl = "\u002fproposedrevision\u002fLists\u002fRelated\u002520Links\u002fEditForm.aspx";
ctx.isWebEditorPreview = 0;
ctx.ctxId = 1;
g_ViewIdToViewCounterMap[ "{3CF5E074-39B0-425F-92E8-F3C760A6CE71}" ]= 1;
ctx.CurrentUserId = -1;
ctx1 = ctx;
</script><tr><td><table id="{59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}-{3CF5E074-39B0-425F-92E8-F3C760A6CE71}" summary="Related Links" o:webquerysourcehref="http://www.dsm5.org/proposedrevision/_vti_bin/owssvr.dll?CS=65001&amp;XMLDATA=1&amp;RowLimit=0&amp;List={59E5C57E-4B33-4F74-B28B-5BDB9754C4FB}&amp;View={3CF5E074-39B0-425F-92E8-F3C760A6CE71}" class="ms-summarycustombody" style="margin-bottom: 5px;" cellpadding="0" cellspacing="0" border="0">
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="http://www.psych.org/">American Psychiatric Association</a>
                            </td>
                        </tr>
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="../../proposedrevision/Pages/proposed-dsm5-organizational-structure-and-disorder-names.html">Proposed DSM-5 Organizational Structure</a>
                            </td>
                        </tr>
                        <tr>
                            <td style="padding-bottom: 5px" class="ms-vb"><img src="../../_layouts/images/square.gif" alt="">&nbsp;</td>
                            <td style="padding-bottom: 5px;padding-left: 5px;" class="ms-vb">
                        <a onfocus="OnLink(this)" href="../../Pages/RecentUpdates.html">Recent Updates to Proposed Revisions for DSM-5</a>
                            </td>
                        </tr>
                    </table></td></tr></table><table id="ECBItems" style="display:none" height="0" width="0"><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XsnLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xsn</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.2</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.3</td><td>255</td></tr><tr><td>Edit in Browser</td><td>/_layouts/images/icxddoc.gif</td><td>/proposedrevision/_layouts/formserver.aspx?XmlLocation={ItemUrl}&OpenIn;=Browser</td><td>0x0</td><td>0x1</td><td>ProgId</td><td>InfoPath.Document.4</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>255</td></tr><tr><td>View in Web Browser</td><td>/_layouts/images/ichtmxls.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&DefaultItemOpen;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>255</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsx</td><td>256</td></tr><tr><td>Snapshot in Excel</td><td>/_layouts/images/ewr134.gif</td><td>/proposedrevision/_layouts/xlviewer.aspx?listguid={ListId}&itemid;={ItemId}&Snapshot;=1</td><td>0x0</td><td>0x1</td><td>FileType</td><td>xlsb</td><td>256</td></tr></table></div></td>
			</tr>
		</table></td>
	</tr>
</table>						
		</div>						
	</div>	
	<div class="DSM_clear"><img src="../../Style Library/DSM_Images/clear.gif" width="1" height="1" alt=""/></div>	
<!---- end MAIN CONTENT AREA ---->
			</div>
			<div id="DSM_Footer">
				<p class="DSM_Tagline">Representing 36,000 physician leaders in mental health.</p>
				<p>© <strong>2012 American Psychiatric Association.</strong> All Rights Reserved.<br/>
				Use of all Materials on this Website is subject to the <a href="../../Pages/PermissionsPolicy.html">APA Permissions Policy</a> and <a href="../../Pages/TermsandConditionsofUse.html">Terms and Conditions of Use.</a><br/>
				<br/>  
				1000 Wilson Boulevard, Suite 1825, Arlington, Va. 22209-3901<br/>
				phone: 703-907-7300 <a href="mailto:apa@psych.org?subject=DSM5:">email: apa@psych.org</a></p>
				<div class="DSM_SocialLinks">
	 				<table>
	 					<tr>
	 						<td>Find us on:</td>
							<td><a href="http://www.facebook.com/pages/DSM-5-Diagnostic-and-Statistical-Manual-of-Mental-Disorders/260197062886" target="_blank"><img src="../../Style Library/DSM_Images/facebook.gif" width="58" height="15" alt="Find us on Facebook"/></a></td>
							<td><a href="http://twitter.com/dsm5" target="_blank"><img src="../../Style Library/DSM_Images/twitter.jpg" width="60" height="20" alt="Find us on Twitter"/></a></td>
						</tr>
	 				</table>
				</div>
				<p><a href="../../pages/Contactus.html">Contact Us For Help</a></p>
			</div>		
		</div>
<!-- end MAIN LAYOUT -->
<!-- begin EDITOR POSITIONING DIV -->
	<div id="ctl00_MSO_ContentDiv" class="SP_editorPosition">&nbsp;</div>
<!-- end EDITOR POSITIONING DIV -->
<!-- begin HIDDEN MASTER PAGE ELEMENTS -->
	<div style="display:none">
			<div class="breadcrumb">
				<span id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath"><a href="#ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"><img alt="Skip Navigation Links" height="0" width="0" src="../../WebResource.axd_d_nmHMzpcb8opA4_TBGiLLxg2_t_633965588901821931.jpg" border="0"/></a><span><a class="ms-sitemapdirectional" href="/">Home</a></span><span> &gt; </span><span><a title="DSM-5 Proposed Revisions" class="ms-sitemapdirectional" href="../../proposedrevision/Pages/Default.html">Proposed Revisions</a></span><span> &gt; </span><span class="breadcrumbCurrent">Proposed Revision</span><a id="ctl00_PlaceHolderTitleBreadcrumb_siteMapPath_SkipLink"></a></span>
			</div>
	</div>
<!-- end HIDDEN MASTER PAGE ELEMENTS -->
<script type="text/javascript">
//<![CDATA[
var __wpmExportWarning='This Web Part Page has been personalized. As a result, one or more Web Part properties may contain confidential information. Make sure the properties contain information that is safe for others to read. After exporting this Web Part, view properties in the Web Part description file (.WebPart) by using a text editor such as Microsoft Notepad.';var __wpmCloseProviderWarning='You are about to close this Web Part.  It is currently providing data to other Web Parts, and these connections will be deleted if this Web Part is closed.  To close this Web Part, click OK.  To keep this Web Part, click Cancel.';var __wpmDeleteWarning='You are about to permanently delete this Web Part.  Are you sure you want to do this?  To delete this Web Part, click OK.  To keep this Web Part, click Cancel.';var zz1_TopNavigationMenu_Data = new Object();
zz1_TopNavigationMenu_Data.disappearAfter = 500;
zz1_TopNavigationMenu_Data.horizontalOffset = 0;
zz1_TopNavigationMenu_Data.verticalOffset = 0;
zz1_TopNavigationMenu_Data.hoverClass = 'DSM_dynamicNavHover';
if (typeof(overrideMenu_HoverStatic) == 'function' && typeof(Menu_HoverStatic) == 'function')
{
_spBodyOnLoadFunctionNames.push('enableFlyoutsAfterDelay');
Menu_HoverStatic = overrideMenu_HoverStatic;
}
var flyoutsAllowed = false;
function enableFlyoutsAfterDelay()
{
setTimeout('flyoutsAllowed = true;', 50);
}
function overrideMenu_HoverStatic(item)
{
if (!flyoutsAllowed || (document.readyState != null && document.readyState != 'complete'))
{
setTimeout(delayMenu_HoverStatic(item), 50);
}
else
{
// this code is the default ASP.NET implementation of Menu_HoverStatic
var node = Menu_HoverRoot(item);
var data = Menu_GetData(item);
if (!data) return;
__disappearAfter = data.disappearAfter;
Menu_Expand(node, data.horizontalOffset, data.verticalOffset);
}
}
function delayMenu_HoverStatic(item)
{
return (function()
{
overrideMenu_HoverStatic(item);
});
}
//]]>
</script>
</form>
  <!-- Google Code -->
  <script type="text/javascript">
  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-16139255-17']);
  _gaq.push(['_setDomainName', '.dsm5.org']);
  _gaq.push(['_trackPageview']);
  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + 
'.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();
</script>
</body>
</html>